Robert J. Fox

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al. · Neurology · 2014 · 3.1K citations · Full text

Medicine, Neurology, Pathology +17

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold et al. · New England Journal of Medicine · 2008 · 2.4K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Robert J. Fox, David H. Miller, J. Theodore Phillips et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text

Medicine, Neurology, Pharmacology +6

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

Ranjan Dutta, Jennifer McDonough, Xinghua Yin et al. · Annals of Neurology · 2006 · 832 citations

Life Sciences, Neurology, Neuroscience +17